Bioethics in Practice: Therapeutic Misconception

REFERENCES

1. ↵
   1. Henderson GE,
   2. Churchill LR,
   3. Davis AM,
   4. et al.

   Clinical trials and medical care: defining the therapeutic misconception. PLoS Med. 2007 11 27; 4 11: e324. pmid:18044980

   OpenUrlCrossRefPubMed
2. ↵
   The Belmont Report. Office for Human Research Protections. U.S. Department of Health and Human Services. http://www.hhs.gov/ohrp/regulations-and-policy/belmont-report/. Published April 18, 1979. Accessed September 26, 2016.
3. ↵
   1. Pentz RD,
   2. White M,
   3. Harvey RD,
   4. et al.

   Therapeutic misconception, misestimation, and optimism in participants enrolled in phase 1 trials. Cancer. 2012 9 15; 118 18: 4571- 4578. doi: 10.1002/cncr.27397. pmid:22294385

   OpenUrlCrossRefPubMedWeb of Science
4. ↵
   General requirements for informed consent. 21 CFR 50.20 et seq. Revised April 1, 2016. http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/cfrsearch.cfm?fr=50.20. Accessed September 26, 2016.
5. ↵
   Basic HHS policy for protection of human research subjects. 45 CFR 46.101 et seq. Revised January 15, 2009. http://www.hhs.gov/ohrp/regulations-and-policy/regulations/45-cfr-46/. Accessed September 26, 2016.
6. Uniform consent law. La. R.S. 40:1157.1 et seq. http://legis.la.gov/legis/Law.aspx?d=964692. Accessed September 26, 2016.
7. ↵
   Elements of informed consent. 21 CFR 50.25. Revised April 1, 2016. http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/cfrsearch.cfm?fr=50.25. Accessed September 26, 2016.
8. ↵
   A Guide to Informed Consent – Information Sheet. U.S. Food and Drug Administration. http://www.fda.gov/RegulatoryInformation/Guidances/ucm126431.htm. Updated January 25, 2016. Accessed September 26, 2016.